nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—ESR1—liver cancer	0.317	0.556	CbGaD
Melatonin—CYP1A1—liver cancer	0.254	0.444	CbGaD
Melatonin—CYP1B1—Doxorubicin—liver cancer	0.0538	0.509	CbGbCtD
Melatonin—MPO—superior mesenteric artery—liver cancer	0.0309	0.582	CbGeAlD
Melatonin—CYP2C19—Sorafenib—liver cancer	0.0189	0.178	CbGbCtD
Melatonin—CYP1A2—Sorafenib—liver cancer	0.0174	0.164	CbGbCtD
Melatonin—CYP2C9—Sorafenib—liver cancer	0.0157	0.148	CbGbCtD
Melatonin—CALR—gall bladder—liver cancer	0.00557	0.105	CbGeAlD
Melatonin—CALR—embryo—liver cancer	0.00353	0.0666	CbGeAlD
Melatonin—CALM2—gall bladder—liver cancer	0.00171	0.0322	CbGeAlD
Melatonin—CALR—liver—liver cancer	0.00163	0.0308	CbGeAlD
Melatonin—Proteinuria—Sorafenib—liver cancer	0.0015	0.018	CcSEcCtD
Melatonin—Protein urine present—Sorafenib—liver cancer	0.00148	0.0177	CcSEcCtD
Melatonin—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00146	0.0175	CcSEcCtD
Melatonin—Hypocalcaemia—Sorafenib—liver cancer	0.00144	0.0173	CcSEcCtD
Melatonin—Mouth ulceration—Sorafenib—liver cancer	0.00119	0.0143	CcSEcCtD
Melatonin—Laboratory test abnormal—Epirubicin—liver cancer	0.00117	0.014	CcSEcCtD
Melatonin—ESR1—embryo—liver cancer	0.00109	0.0205	CbGeAlD
Melatonin—CALM2—embryo—liver cancer	0.00108	0.0204	CbGeAlD
Melatonin—Laboratory test abnormal—Doxorubicin—liver cancer	0.00108	0.0129	CcSEcCtD
Melatonin—CALM1—embryo—liver cancer	0.00108	0.0203	CbGeAlD
Melatonin—Eczema—Sorafenib—liver cancer	0.00106	0.0128	CcSEcCtD
Melatonin—Hyponatraemia—Sorafenib—liver cancer	0.00096	0.0115	CcSEcCtD
Melatonin—Pain in extremity—Sorafenib—liver cancer	0.000956	0.0115	CcSEcCtD
Melatonin—NQO2—liver—liver cancer	0.000921	0.0174	CbGeAlD
Melatonin—Mood swings—Sorafenib—liver cancer	0.000906	0.0109	CcSEcCtD
Melatonin—Dry skin—Sorafenib—liver cancer	0.000876	0.0105	CcSEcCtD
Melatonin—Abdominal pain upper—Sorafenib—liver cancer	0.000873	0.0105	CcSEcCtD
Melatonin—Breast disorder—Sorafenib—liver cancer	0.000864	0.0104	CcSEcCtD
Melatonin—Nasopharyngitis—Sorafenib—liver cancer	0.000855	0.0103	CcSEcCtD
Melatonin—Gastritis—Sorafenib—liver cancer	0.000846	0.0101	CcSEcCtD
Melatonin—Abdominal discomfort—Sorafenib—liver cancer	0.000792	0.0095	CcSEcCtD
Melatonin—Psoriasis—Epirubicin—liver cancer	0.000774	0.00929	CcSEcCtD
Melatonin—Nail disorder—Epirubicin—liver cancer	0.00075	0.009	CcSEcCtD
Melatonin—Infestation—Sorafenib—liver cancer	0.000737	0.00884	CcSEcCtD
Melatonin—Infestation NOS—Sorafenib—liver cancer	0.000737	0.00884	CcSEcCtD
Melatonin—Stomatitis—Sorafenib—liver cancer	0.000718	0.00861	CcSEcCtD
Melatonin—Psoriasis—Doxorubicin—liver cancer	0.000716	0.0086	CcSEcCtD
Melatonin—MPO—liver—liver cancer	0.000709	0.0134	CbGeAlD
Melatonin—Hepatobiliary disease—Sorafenib—liver cancer	0.000697	0.00836	CcSEcCtD
Melatonin—Nail disorder—Doxorubicin—liver cancer	0.000694	0.00833	CcSEcCtD
Melatonin—Urinary tract disorder—Sorafenib—liver cancer	0.000653	0.00784	CcSEcCtD
Melatonin—Connective tissue disorder—Sorafenib—liver cancer	0.00065	0.0078	CcSEcCtD
Melatonin—Urethral disorder—Sorafenib—liver cancer	0.000648	0.00778	CcSEcCtD
Melatonin—Herpes zoster—Epirubicin—liver cancer	0.000646	0.00775	CcSEcCtD
Melatonin—CALM3—liver—liver cancer	0.000637	0.012	CbGeAlD
Melatonin—Cardiac disorder—Sorafenib—liver cancer	0.000614	0.00736	CcSEcCtD
Melatonin—Glycosuria—Epirubicin—liver cancer	0.000601	0.00721	CcSEcCtD
Melatonin—Angiopathy—Sorafenib—liver cancer	0.0006	0.0072	CcSEcCtD
Melatonin—Herpes zoster—Doxorubicin—liver cancer	0.000598	0.00717	CcSEcCtD
Melatonin—Immune system disorder—Sorafenib—liver cancer	0.000597	0.00717	CcSEcCtD
Melatonin—CYP19A1—liver—liver cancer	0.000579	0.0109	CbGeAlD
Melatonin—Mental disorder—Sorafenib—liver cancer	0.000579	0.00695	CcSEcCtD
Melatonin—Malnutrition—Sorafenib—liver cancer	0.000576	0.00691	CcSEcCtD
Melatonin—Erythema—Sorafenib—liver cancer	0.000576	0.00691	CcSEcCtD
Melatonin—Glycosuria—Doxorubicin—liver cancer	0.000556	0.00667	CcSEcCtD
Melatonin—Muscle spasms—Sorafenib—liver cancer	0.000553	0.00664	CcSEcCtD
Melatonin—CYP1B1—liver—liver cancer	0.000542	0.0102	CbGeAlD
Melatonin—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000535	0.00642	CcSEcCtD
Melatonin—Hypocalcaemia—Epirubicin—liver cancer	0.000532	0.00638	CcSEcCtD
Melatonin—Lacrimation increased—Epirubicin—liver cancer	0.000528	0.00634	CcSEcCtD
Melatonin—Angioedema—Sorafenib—liver cancer	0.000526	0.00631	CcSEcCtD
Melatonin—Nocturia—Epirubicin—liver cancer	0.000525	0.00629	CcSEcCtD
Melatonin—Syncope—Sorafenib—liver cancer	0.000516	0.00619	CcSEcCtD
Melatonin—Leukopenia—Sorafenib—liver cancer	0.000515	0.00618	CcSEcCtD
Melatonin—Loss of consciousness—Sorafenib—liver cancer	0.000506	0.00607	CcSEcCtD
Melatonin—ESR1—liver—liver cancer	0.000504	0.00949	CbGeAlD
Melatonin—CALM2—liver—liver cancer	0.000501	0.00943	CbGeAlD
Melatonin—CALM1—liver—liver cancer	0.000498	0.00939	CbGeAlD
Melatonin—Hypertension—Sorafenib—liver cancer	0.000497	0.00596	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.000495	0.00594	CcSEcCtD
Melatonin—Neck pain—Epirubicin—liver cancer	0.000493	0.00591	CcSEcCtD
Melatonin—Hypocalcaemia—Doxorubicin—liver cancer	0.000492	0.0059	CcSEcCtD
Melatonin—Arthralgia—Sorafenib—liver cancer	0.00049	0.00588	CcSEcCtD
Melatonin—Lacrimation increased—Doxorubicin—liver cancer	0.000489	0.00586	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000487	0.00584	CcSEcCtD
Melatonin—Nocturia—Doxorubicin—liver cancer	0.000485	0.00582	CcSEcCtD
Melatonin—Abnormal dreams—Epirubicin—liver cancer	0.000481	0.00577	CcSEcCtD
Melatonin—Dry mouth—Sorafenib—liver cancer	0.000479	0.00575	CcSEcCtD
Melatonin—CYP2C19—liver—liver cancer	0.000475	0.00896	CbGeAlD
Melatonin—Salivary hypersecretion—Epirubicin—liver cancer	0.000473	0.00567	CcSEcCtD
Melatonin—Infection—Sorafenib—liver cancer	0.000467	0.0056	CcSEcCtD
Melatonin—Shock—Sorafenib—liver cancer	0.000462	0.00555	CcSEcCtD
Melatonin—Nervous system disorder—Sorafenib—liver cancer	0.000461	0.00553	CcSEcCtD
Melatonin—Thrombocytopenia—Sorafenib—liver cancer	0.00046	0.00552	CcSEcCtD
Melatonin—Skin disorder—Sorafenib—liver cancer	0.000456	0.00548	CcSEcCtD
Melatonin—Neck pain—Doxorubicin—liver cancer	0.000456	0.00547	CcSEcCtD
Melatonin—Abnormal dreams—Doxorubicin—liver cancer	0.000445	0.00534	CcSEcCtD
Melatonin—Mouth ulceration—Epirubicin—liver cancer	0.00044	0.00528	CcSEcCtD
Melatonin—Salivary hypersecretion—Doxorubicin—liver cancer	0.000437	0.00525	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000428	0.00514	CcSEcCtD
Melatonin—Dyspepsia—Sorafenib—liver cancer	0.000414	0.00496	CcSEcCtD
Melatonin—Mouth ulceration—Doxorubicin—liver cancer	0.000407	0.00488	CcSEcCtD
Melatonin—Gastrointestinal disorder—Sorafenib—liver cancer	0.000406	0.00487	CcSEcCtD
Melatonin—Fatigue—Sorafenib—liver cancer	0.000405	0.00486	CcSEcCtD
Melatonin—Pain—Sorafenib—liver cancer	0.000402	0.00482	CcSEcCtD
Melatonin—Eczema—Epirubicin—liver cancer	0.000393	0.00472	CcSEcCtD
Melatonin—CYP1A2—liver—liver cancer	0.000388	0.00732	CbGeAlD
Melatonin—Gastrointestinal pain—Sorafenib—liver cancer	0.000384	0.00461	CcSEcCtD
Melatonin—CYP1A1—liver—liver cancer	0.000383	0.00722	CbGeAlD
Melatonin—Hot flush—Epirubicin—liver cancer	0.000378	0.00453	CcSEcCtD
Melatonin—Menopausal symptoms—Epirubicin—liver cancer	0.000374	0.00449	CcSEcCtD
Melatonin—Abdominal pain—Sorafenib—liver cancer	0.000371	0.00446	CcSEcCtD
Melatonin—CYP2C9—liver—liver cancer	0.000368	0.00695	CbGeAlD
Melatonin—Eczema—Doxorubicin—liver cancer	0.000364	0.00436	CcSEcCtD
Melatonin—Lethargy—Epirubicin—liver cancer	0.00036	0.00433	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—liver cancer	0.000355	0.00426	CcSEcCtD
Melatonin—Pain in extremity—Epirubicin—liver cancer	0.000353	0.00424	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—liver cancer	0.000349	0.00419	CcSEcCtD
Melatonin—Affect lability—Epirubicin—liver cancer	0.000348	0.00417	CcSEcCtD
Melatonin—Migraine—Epirubicin—liver cancer	0.000348	0.00417	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—liver cancer	0.000346	0.00416	CcSEcCtD
Melatonin—Hypersensitivity—Sorafenib—liver cancer	0.000346	0.00415	CcSEcCtD
Melatonin—Asthenia—Sorafenib—liver cancer	0.000337	0.00404	CcSEcCtD
Melatonin—Mood swings—Epirubicin—liver cancer	0.000335	0.00402	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—liver cancer	0.000334	0.004	CcSEcCtD
Melatonin—Pruritus—Sorafenib—liver cancer	0.000332	0.00399	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—liver cancer	0.000328	0.00394	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—liver cancer	0.000327	0.00392	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—liver cancer	0.000326	0.00391	CcSEcCtD
Melatonin—Dry skin—Epirubicin—liver cancer	0.000324	0.00388	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—liver cancer	0.000323	0.00387	CcSEcCtD
Melatonin—Migraine—Doxorubicin—liver cancer	0.000322	0.00386	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—liver cancer	0.000322	0.00386	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—liver cancer	0.000319	0.00383	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—liver cancer	0.000316	0.00379	CcSEcCtD
Melatonin—Gastritis—Epirubicin—liver cancer	0.000313	0.00375	CcSEcCtD
Melatonin—Dizziness—Sorafenib—liver cancer	0.000311	0.00373	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—liver cancer	0.00031	0.00372	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—liver cancer	0.000302	0.00362	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—liver cancer	0.0003	0.00359	CcSEcCtD
Melatonin—Vomiting—Sorafenib—liver cancer	0.000299	0.00358	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—liver cancer	0.000299	0.00358	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—liver cancer	0.000297	0.00357	CcSEcCtD
Melatonin—Rash—Sorafenib—liver cancer	0.000296	0.00355	CcSEcCtD
Melatonin—Dermatitis—Sorafenib—liver cancer	0.000296	0.00355	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—liver cancer	0.000295	0.00354	CcSEcCtD
Melatonin—Headache—Sorafenib—liver cancer	0.000294	0.00353	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—liver cancer	0.000292	0.00351	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—liver cancer	0.000289	0.00347	CcSEcCtD
Melatonin—Nausea—Sorafenib—liver cancer	0.000279	0.00335	CcSEcCtD
Melatonin—Weight increased—Epirubicin—liver cancer	0.000278	0.00333	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—liver cancer	0.000275	0.0033	CcSEcCtD
Melatonin—Infestation—Epirubicin—liver cancer	0.000272	0.00327	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—liver cancer	0.000272	0.00327	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—liver cancer	0.000265	0.00318	CcSEcCtD
Melatonin—Haematuria—Epirubicin—liver cancer	0.00026	0.00311	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—liver cancer	0.000257	0.00309	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—liver cancer	0.000257	0.00308	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—liver cancer	0.000252	0.00302	CcSEcCtD
Melatonin—Infestation—Doxorubicin—liver cancer	0.000252	0.00302	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—liver cancer	0.000246	0.00295	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—liver cancer	0.000241	0.0029	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—liver cancer	0.00024	0.00288	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—liver cancer	0.00024	0.00288	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—liver cancer	0.00024	0.00287	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—liver cancer	0.000238	0.00286	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—liver cancer	0.000228	0.00274	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—liver cancer	0.000227	0.00272	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—liver cancer	0.000223	0.00268	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—liver cancer	0.000222	0.00267	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—liver cancer	0.000222	0.00266	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—liver cancer	0.000222	0.00266	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—liver cancer	0.000221	0.00265	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—liver cancer	0.000214	0.00257	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—liver cancer	0.000213	0.00255	CcSEcCtD
Melatonin—Erythema—Epirubicin—liver cancer	0.000213	0.00255	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—liver cancer	0.000211	0.00254	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—liver cancer	0.00021	0.00252	CcSEcCtD
Melatonin—Flatulence—Epirubicin—liver cancer	0.00021	0.00252	CcSEcCtD
Melatonin—Tension—Epirubicin—liver cancer	0.000209	0.0025	CcSEcCtD
Melatonin—Nervousness—Epirubicin—liver cancer	0.000207	0.00248	CcSEcCtD
Melatonin—Back pain—Epirubicin—liver cancer	0.000206	0.00247	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—liver cancer	0.000205	0.00246	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—liver cancer	0.000205	0.00245	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—liver cancer	0.000204	0.00245	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—liver cancer	0.0002	0.00241	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—liver cancer	0.000198	0.00238	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—liver cancer	0.000197	0.00236	CcSEcCtD
Melatonin—Erythema—Doxorubicin—liver cancer	0.000197	0.00236	CcSEcCtD
Melatonin—Agitation—Epirubicin—liver cancer	0.000195	0.00235	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—liver cancer	0.000194	0.00233	CcSEcCtD
Melatonin—Tension—Doxorubicin—liver cancer	0.000193	0.00232	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—liver cancer	0.000191	0.00229	CcSEcCtD
Melatonin—Vertigo—Epirubicin—liver cancer	0.000191	0.00229	CcSEcCtD
Melatonin—Syncope—Epirubicin—liver cancer	0.000191	0.00229	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—liver cancer	0.00019	0.00228	CcSEcCtD
Melatonin—Back pain—Doxorubicin—liver cancer	0.00019	0.00228	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—liver cancer	0.000189	0.00227	CcSEcCtD
Melatonin—Palpitations—Epirubicin—liver cancer	0.000188	0.00226	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—liver cancer	0.000187	0.00224	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—liver cancer	0.000186	0.00223	CcSEcCtD
Melatonin—Hypertension—Epirubicin—liver cancer	0.000184	0.0022	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—liver cancer	0.000181	0.00217	CcSEcCtD
Melatonin—Chest pain—Epirubicin—liver cancer	0.000181	0.00217	CcSEcCtD
Melatonin—Agitation—Doxorubicin—liver cancer	0.000181	0.00217	CcSEcCtD
Melatonin—Anxiety—Epirubicin—liver cancer	0.00018	0.00217	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00018	0.00216	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—liver cancer	0.000177	0.00213	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—liver cancer	0.000177	0.00212	CcSEcCtD
Melatonin—Syncope—Doxorubicin—liver cancer	0.000177	0.00212	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—liver cancer	0.000176	0.00211	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—liver cancer	0.000174	0.00209	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—liver cancer	0.000173	0.00208	CcSEcCtD
Melatonin—Infection—Epirubicin—liver cancer	0.000172	0.00207	CcSEcCtD
Melatonin—Shock—Epirubicin—liver cancer	0.000171	0.00205	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—liver cancer	0.00017	0.00204	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—liver cancer	0.00017	0.00204	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—liver cancer	0.00017	0.00204	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—liver cancer	0.000169	0.00202	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—liver cancer	0.000168	0.00201	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—liver cancer	0.000168	0.00201	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—liver cancer	0.000167	0.002	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000166	0.002	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—liver cancer	0.000164	0.00197	CcSEcCtD
Melatonin—Infection—Doxorubicin—liver cancer	0.00016	0.00191	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000158	0.0019	CcSEcCtD
Melatonin—Shock—Doxorubicin—liver cancer	0.000158	0.0019	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—liver cancer	0.000158	0.00189	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—liver cancer	0.000157	0.00189	CcSEcCtD
Melatonin—Insomnia—Epirubicin—liver cancer	0.000157	0.00188	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—liver cancer	0.000156	0.00187	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—liver cancer	0.000156	0.00187	CcSEcCtD
Melatonin—Somnolence—Epirubicin—liver cancer	0.000154	0.00185	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—liver cancer	0.000153	0.00183	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Melatonin—Fatigue—Epirubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Melatonin—Pain—Epirubicin—liver cancer	0.000148	0.00178	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000146	0.00176	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—liver cancer	0.000145	0.00174	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—liver cancer	0.000144	0.00173	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—liver cancer	0.000143	0.00171	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—liver cancer	0.000142	0.0017	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—liver cancer	0.000141	0.0017	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000139	0.00166	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—liver cancer	0.000139	0.00166	CcSEcCtD
Melatonin—Pain—Doxorubicin—liver cancer	0.000137	0.00165	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—liver cancer	0.000137	0.00165	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000131	0.00158	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—liver cancer	0.000128	0.00153	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—liver cancer	0.000127	0.00152	CcSEcCtD
Melatonin—Asthenia—Epirubicin—liver cancer	0.000125	0.00149	CcSEcCtD
Melatonin—Pruritus—Epirubicin—liver cancer	0.000123	0.00147	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—liver cancer	0.000118	0.00142	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—liver cancer	0.000115	0.00138	CcSEcCtD
Melatonin—Dizziness—Epirubicin—liver cancer	0.000115	0.00138	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—liver cancer	0.000114	0.00136	CcSEcCtD
Melatonin—Vomiting—Epirubicin—liver cancer	0.00011	0.00132	CcSEcCtD
Melatonin—Rash—Epirubicin—liver cancer	0.000109	0.00131	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—liver cancer	0.000109	0.00131	CcSEcCtD
Melatonin—Headache—Epirubicin—liver cancer	0.000109	0.00131	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—liver cancer	0.000106	0.00127	CcSEcCtD
Melatonin—Nausea—Epirubicin—liver cancer	0.000103	0.00124	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—liver cancer	0.000102	0.00123	CcSEcCtD
Melatonin—Rash—Doxorubicin—liver cancer	0.000101	0.00122	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—liver cancer	0.000101	0.00121	CcSEcCtD
Melatonin—Headache—Doxorubicin—liver cancer	0.000101	0.00121	CcSEcCtD
Melatonin—Nausea—Doxorubicin—liver cancer	9.54e-05	0.00114	CcSEcCtD
Melatonin—CALM2—Immune System—IL2—liver cancer	3.97e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2—liver cancer	3.97e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CD—liver cancer	3.96e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—liver cancer	3.96e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KDR—liver cancer	3.96e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KDR—liver cancer	3.96e-06	2.12e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HMOX1—liver cancer	3.94e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—F2—liver cancer	3.94e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK14—liver cancer	3.93e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK14—liver cancer	3.93e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ALB—liver cancer	3.91e-06	2.09e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CDKN1B—liver cancer	3.88e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CDKN1B—liver cancer	3.87e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CDKN1A—liver cancer	3.87e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—JUN—liver cancer	3.86e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—JUN—liver cancer	3.86e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ESR1—liver cancer	3.86e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ESR1—liver cancer	3.86e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CD—liver cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CD—liver cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—liver cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—liver cancer	3.83e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—AKT1—liver cancer	3.82e-06	2.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—F2—liver cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—F2—liver cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CASP3—liver cancer	3.8e-06	2.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2—liver cancer	3.8e-06	2.03e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—MTHFR—liver cancer	3.8e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ALB—liver cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ALB—liver cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK8—liver cancer	3.78e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APC—liver cancer	3.77e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CG—liver cancer	3.77e-06	2.02e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CD—liver cancer	3.76e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1B—liver cancer	3.74e-06	2e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1B—liver cancer	3.74e-06	2e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CDKN1A—liver cancer	3.74e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CDKN1A—liver cancer	3.74e-06	2e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARA—liver cancer	3.73e-06	1.99e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ALB—liver cancer	3.71e-06	1.99e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—liver cancer	3.7e-06	1.98e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—JUN—liver cancer	3.7e-06	1.98e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—liver cancer	3.69e-06	1.98e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—liver cancer	3.69e-06	1.98e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTM1—liver cancer	3.67e-06	1.97e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.67e-06	1.97e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—liver cancer	3.67e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—liver cancer	3.67e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—liver cancer	3.66e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK8—liver cancer	3.65e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK8—liver cancer	3.65e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CG—liver cancer	3.65e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APC—liver cancer	3.65e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APC—liver cancer	3.65e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CG—liver cancer	3.65e-06	1.95e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—liver cancer	3.6e-06	1.93e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CDKN1A—liver cancer	3.58e-06	1.92e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CDKN1A—liver cancer	3.57e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—liver cancer	3.55e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—liver cancer	3.55e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—BRAF—liver cancer	3.54e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—liver cancer	3.54e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—liver cancer	3.54e-06	1.89e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CG—liver cancer	3.5e-06	1.87e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK8—liver cancer	3.5e-06	1.87e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP1A1—liver cancer	3.48e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1A—liver cancer	3.45e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1A—liver cancer	3.45e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—liver cancer	3.45e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—liver cancer	3.45e-06	1.85e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—liver cancer	3.43e-06	1.83e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—liver cancer	3.43e-06	1.83e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—liver cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—liver cancer	3.37e-06	1.8e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.35e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—liver cancer	3.34e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—liver cancer	3.34e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—liver cancer	3.34e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—liver cancer	3.34e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—liver cancer	3.31e-06	1.77e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—liver cancer	3.28e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SERPINE1—liver cancer	3.28e-06	1.75e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—liver cancer	3.25e-06	1.74e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—liver cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—liver cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—liver cancer	3.23e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—liver cancer	3.2e-06	1.72e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—liver cancer	3.2e-06	1.72e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—liver cancer	3.2e-06	1.71e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—liver cancer	3.19e-06	1.71e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—liver cancer	3.19e-06	1.71e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARA—liver cancer	3.18e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SERPINE1—liver cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SERPINE1—liver cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—liver cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—liver cancer	3.14e-06	1.68e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—liver cancer	3.14e-06	1.68e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—liver cancer	3.08e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—liver cancer	3.08e-06	1.65e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—liver cancer	3.08e-06	1.65e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—liver cancer	3.08e-06	1.65e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—liver cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—liver cancer	2.98e-06	1.6e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—liver cancer	2.97e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—liver cancer	2.96e-06	1.59e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—liver cancer	2.96e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—liver cancer	2.96e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RAF1—liver cancer	2.96e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—liver cancer	2.95e-06	1.58e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—liver cancer	2.89e-06	1.55e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—liver cancer	2.89e-06	1.55e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—liver cancer	2.88e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—liver cancer	2.88e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—liver cancer	2.87e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—liver cancer	2.87e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RAF1—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RAF1—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—liver cancer	2.86e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—liver cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—liver cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—liver cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—liver cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—liver cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—liver cancer	2.77e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—liver cancer	2.76e-06	1.48e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—liver cancer	2.75e-06	1.47e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—liver cancer	2.74e-06	1.47e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—liver cancer	2.74e-06	1.47e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—liver cancer	2.73e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—liver cancer	2.72e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—liver cancer	2.71e-06	1.45e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—liver cancer	2.68e-06	1.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—liver cancer	2.67e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—liver cancer	2.67e-06	1.43e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—liver cancer	2.66e-06	1.42e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—liver cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—liver cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—liver cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—liver cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—liver cancer	2.64e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—liver cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—liver cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—liver cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—liver cancer	2.62e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—liver cancer	2.62e-06	1.4e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—liver cancer	2.59e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—liver cancer	2.58e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—liver cancer	2.57e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—liver cancer	2.57e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—liver cancer	2.57e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—liver cancer	2.57e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—liver cancer	2.56e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—liver cancer	2.55e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—liver cancer	2.55e-06	1.37e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—liver cancer	2.52e-06	1.35e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—liver cancer	2.52e-06	1.35e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—liver cancer	2.51e-06	1.35e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—liver cancer	2.51e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—liver cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—liver cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—liver cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—liver cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—liver cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—liver cancer	2.48e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—liver cancer	2.48e-06	1.33e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—liver cancer	2.45e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK8—liver cancer	2.44e-06	1.31e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—liver cancer	2.44e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—liver cancer	2.44e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—liver cancer	2.44e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—liver cancer	2.43e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—liver cancer	2.43e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—liver cancer	2.43e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—liver cancer	2.43e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—liver cancer	2.43e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—liver cancer	2.42e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—liver cancer	2.42e-06	1.3e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—liver cancer	2.41e-06	1.29e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—liver cancer	2.4e-06	1.28e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—liver cancer	2.37e-06	1.27e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK8—liver cancer	2.36e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK8—liver cancer	2.36e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—liver cancer	2.35e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—liver cancer	2.35e-06	1.26e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—liver cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—liver cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—liver cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—liver cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—liver cancer	2.25e-06	1.21e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—liver cancer	2.25e-06	1.2e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—liver cancer	2.25e-06	1.2e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—liver cancer	2.23e-06	1.2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—liver cancer	2.23e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—liver cancer	2.23e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—liver cancer	2.22e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—liver cancer	2.18e-06	1.17e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—liver cancer	2.18e-06	1.17e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—liver cancer	2.16e-06	1.16e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—liver cancer	2.16e-06	1.16e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—liver cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—liver cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—liver cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—liver cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—liver cancer	2.11e-06	1.13e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—liver cancer	2.09e-06	1.12e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—liver cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—liver cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—liver cancer	2.06e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—liver cancer	2.05e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—liver cancer	2.04e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—liver cancer	2.04e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—liver cancer	2.01e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—liver cancer	2.01e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—liver cancer	2e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—liver cancer	2e-06	1.07e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—liver cancer	2e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—liver cancer	1.99e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—liver cancer	1.99e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—liver cancer	1.92e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—liver cancer	1.85e-06	9.92e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—liver cancer	1.85e-06	9.92e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—liver cancer	1.76e-06	9.43e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—liver cancer	1.72e-06	9.21e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—liver cancer	1.7e-06	9.12e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—liver cancer	1.7e-06	9.12e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—liver cancer	1.7e-06	9.12e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—liver cancer	1.66e-06	8.91e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—liver cancer	1.66e-06	8.91e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—liver cancer	1.65e-06	8.82e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—liver cancer	1.65e-06	8.82e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—liver cancer	1.63e-06	8.75e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—liver cancer	1.63e-06	8.74e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—liver cancer	1.63e-06	8.72e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—liver cancer	1.58e-06	8.44e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—liver cancer	1.58e-06	8.44e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—liver cancer	1.56e-06	8.35e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—liver cancer	1.51e-06	8.07e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—liver cancer	1.51e-06	8.07e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—liver cancer	1.49e-06	7.98e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—liver cancer	1.44e-06	7.7e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—liver cancer	1.39e-06	7.45e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—liver cancer	1.39e-06	7.45e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—liver cancer	1.34e-06	7.15e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—liver cancer	1.27e-06	6.82e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—liver cancer	1.22e-06	6.52e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—liver cancer	1.04e-06	5.57e-06	CbGpPWpGaD
